NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Omega Protein Corporation (NYSE:OME) resulting from allegations that Omega may have issued materially misleading business information to the investing public.
On March 1, 2017, Omega revealed during aftermarket hours that in December 2016, it “received a subpoena from the SEC requesting information in connection with an investigation relating to a Company subsidiary’s compliance with its probation terms and the Company’s protection of whistleblower employees.” Omega further revealed that “it is possible that the foregoing matter could result in a material adverse effect on the Company’s business, reputation, results of operation and financial condition.” On this news, shares of Omega fell sharply during intraday trading on March 2, 2017.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Omega investors. If you purchased shares of Omega on or before March 1, 2017, please visit the firm’s website at http://www.rosenlegal.com/cases-1069.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at firstname.lastname@example.org or email@example.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.